Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Epitelijski rak jajčnikov, rak jajcevodov, primarni peritonealni serozni karcinom (PPSC) : priporočila za sistemsko zdravljenje
Avtorji:ID Škof, Erik (Avtor)
ID Cerar, Olga (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,66 MB)
MD5: CF7C26D6ABA97E73F260289C1F9753A1
PID: 20.500.12556/dirros/946923f3-d6b6-46b3-88f4-2f2c9109db0a
 
Jezik:Slovenski jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Ključne besede:rak (medicina), jajčniki, kemoterapija, zdravljenje, smernice
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2015
Št. strani:str. 17-21, 37
Številčenje:Letn. 19, št. 1
PID:20.500.12556/DiRROS-8155 Novo okno
UDK:618.11-006-08
ISSN pri članku:1408-1741
COBISS.SI-ID:2139259 Novo okno
Avtorske pravice:by Authors
Datum objave v DiRROS:19.03.2018
Število ogledov:5454
Število prenosov:1143
Metapodatki:XML DC-XML DC-RDF
:
ŠKOF, Erik in CERAR, Olga, 2015, Epitelijski rak jajčnikov, rak jajcevodov, primarni peritonealni serozni karcinom (PPSC) : priporočila za sistemsko zdravljenje. Onkologija [na spletu]. 2015. Vol. 19, no. 1, p. 17–21, 37. [Dostopano 23 marec 2025]. Pridobljeno s: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=8155
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Onkologija
Skrajšan naslov:Onkologija
Založnik:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:03.01.2018

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Epithelial ovarian cancer, fallopian tube cancer, primary peritoneal serous cancer (PPSC) : systemic treatment recommendations
Povzetek:Epithelial ovarian cancer is known to be one of the most sensitive to systemic treatment with chemotherapy. Objective response to treatment was achieved in more than 80% of patients. Therefore, chemotherapy treatment is a standard part of primary treatment after completed surgery (adjuvant treatment), If surgical treatment is not possible, patients begin treatment with preoperative (neoadjuvant) chemotherapy, which is followed by surgery. In primary systemic treatment, we have been using chemotherapy in combination with taxanes and platinum-based preparations. In systemic treatment of fallopian tube cancer, we also use – besides chemotherapy – bevacizumab, an inhibitor of the vascular endothelial growth factor (VEGF). Systemic treatment presents the principal treatment also in disease recurrence. The type of systemic treatment in disease recurrence depends on the time elapsed since the end of primary treatment until recurrence. In the last couple of years, we have been again witnessing the introduction of new medicines for treatment of patients with fallopian tube cancer. For this reason, the Institute of Oncology Ljubljana this year updated its guidelines for systemic treatment of epithelial ovarian cancer. In this paper, we present the current recommendations for systemic treatment of epithelial ovarian cancer in Slovenia. Epithelial ovarian cancer, fallopian tube cancer and primary peritoneal serous cancer (PPSC) have the same clinical course and the same systemic treatment, therefore they are all managed in the same manner.


Arhiv

niGradiv

Nazaj